Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
In this section, we usually try to help investors determine whether LeanLife Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as LeanLife Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.
Show me the analysis anyway
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
LeanLife Health. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
LeanLife Health's earnings available for a low price, and how does
this compare to other companies in the same industry?
LeanLife Health has negative assets, we can't compare the value of its assets to the CA Food industry average.
Take a look at our analysis of LLP’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through LeanLife Health's regulatory filings and announcements.
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as LeanLife Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Food industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare LeanLife Health's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare LeanLife Health's earnings growth to the Canada market average as no estimate data is available.
Unable to compare LeanLife Health's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if LeanLife Health is high growth as no earnings estimate data is available.
Unable to determine if LeanLife Health is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
LeanLife Health's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Stanislaw L. Lis, also known as Stan, has been Chief Executive Officer and President of Leenlife Pharma International Inc. (also known as SPT - Sulphur Polymer Technologies Inc) since September 2015. Mr. Lis co-founded MicroCoal Technologies Inc. in 2006 and served as its President until February 13, 2014. Mr. Lis served as the Chief Executive Officer of La Jolla Capital Inc. (formerly known as MicroCoal Technologies Inc.) until June 23, 2011. Mr. Lis served as the Chief Executive Officer and President of Net Soft Systems Inc. He served as the President of Stream Communications Network & Media Inc. from February 25, 1994 to August 15, 2005 and Chief Executive Officer from April 23, 1999 to August 15, 2005. He served as Member of Supervisory Board of Stream Communications Sp z o o. He served as President and Chief Executive Officer Director of Trooper Technologies Inc. from 1993 to 2000. He served as President of Avigo Resources Corp. Since April 23, 1999, he has also been performing the function of Chief Executive Officer. He commenced his education in Poland. At the beginning of the 1980s he worked in the finance economy department of AllCorp. In 1988 he founded International UNP Holdings and served as its President from 1989 to 1992. In 1992, he created a joint venture company with the participation of the American company Emergency One and WSK Mielec whose business activities included the production and sale of fire trucks and served as its Vice-President from 1992 to 1994. He has been a Director of Leenlife Pharma International Inc. (also known as SPT - Sulphur Polymer Technologies Inc) since September 2015. He has been Director of Carbon Friendly Solutions, Inc. He served as Director of La Jolla Capital Inc since August 7, 2008 until June 17, 2015. He served as Director of Stream Communications Network & Media, Inc from February 25, 1994 to August 15, 2005 and Trooper Technologies Inc. from 1993 to 2000. He served as a Director of Net Soft Systems Inc. since June 2, 1999. In 1976, Mr. Lis had emigrated to Canada where he continued his studies at the Management and Administration Department, Business Administration and Securities at Simon Fraser University in Vancouver.
Stan's compensation has increased whilst company is loss making.
Stan's remuneration is lower than average for companies of similar size in Canada.
CEO, President & Director
Chief Operating Officer
Dr. Hab Zajac
Chief Financial Officer
Chief Technical Officer
Head of Corporate Development
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the LeanLife Health board of directors is about average.
Board of Directors
CEO, President & Director
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
Imagine Owning LeanLife Health (CNSX:LLP) While The Price Tanked 59%
See our latest analysis for LeanLife Health LeanLife Health didn't have any revenue in the last year, so it's fair to say it doesn't yet have a proven product (or at least not one people are paying for). … Investors will be hoping that LeanLife Health can make progress and gain better traction for the business, before it runs low on cash. … But with the share price diving 59% in the last year, it's probably fair to say that some shareholders no longer believe the company will succeed.
Are LeanLife Health Inc's (CNSX:LLP) Interest Costs Too High?
Investors are always looking for growth in small-cap stocks like LeanLife Health Inc (CNSX:LLP), with a market cap of CA$3.76m. … However, an important fact which most ignore is: how financially healthy is the business? … the current state of its operations and pathway to profitability.
LeanLife Health Inc. produces and sells omega-3 fatty acid products in North America, Europe, and internationally. It offers its products in liquid, emulsion, or powder forms for use in baked goods, processed meats, noodles, beverages, milk products, and chocolates. The company was formerly known as LeenLife Pharma International Inc. and changed its name to LeanLife Health Inc. in January 2018. LeanLife Health Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.